BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 7515782)

  • 21. Bacterial adhesiveness: effects of the SH metabolite of erdosteine (mucoactive drug) plus clarithromycin versus clarithromycin alone.
    Braga PC; Zuccotti T; Dal Sasso M
    Chemotherapy; 2001; 47(3):208-14. PubMed ID: 11306790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Changes in the biological properties of the pertussis microbe exposed to antibiotics].
    Bakulina NA; Efimova OG; Samsonova VS; Bevz NI
    Antibiotiki; 1982 Nov; 27(11):844-50. PubMed ID: 6295258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of bacterial adhesion by sub-inhibitory concentrations: brodimoprim vs trimethoprim.
    Braga PC; Piatti G; Limoli A; Santoro M; Gazzola T
    J Chemother; 1993 Dec; 5(6):447-52. PubMed ID: 8195836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of antibiotics on adherence of Pseudomonas aeruginosa and Pseudomonas fluorescens to A549 pneumocyte cells.
    Di Martino P; Rebière-Huët J; Hulen C
    Chemotherapy; 2000; 46(2):129-34. PubMed ID: 10671764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cholesterol-dependent attachment of human respiratory cells by Bordetella pertussis.
    Lamberti Y; Alvarez Hayes J; Perez Vidakovics ML; Rodriguez ME
    FEMS Immunol Med Microbiol; 2009 Jul; 56(2):143-50. PubMed ID: 19385994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical manifestations of children with microbiologically confirmed pertussis infection and antimicrobial susceptibility of isolated strains in a regional hospital in Japan, 2008-2012.
    Horiba K; Nishimura N; Gotoh K; Kawaguchi M; Takeuchi S; Hattori F; Isaji M; Okai Y; Hosono H; Takemoto K; Ozaki T
    Jpn J Infect Dis; 2014; 67(5):345-8. PubMed ID: 25241683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for an intact polysaccharide capsule in Bordetella pertussis.
    Neo Y; Li R; Howe J; Hoo R; Pant A; Ho S; Alonso S
    Microbes Infect; 2010 Mar; 12(3):238-45. PubMed ID: 20005302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bactericidal effect of antibiotics on Haemophilus influenzae.
    Janovská D; Výmola F
    J Hyg Epidemiol Microbiol Immunol; 1971; 15(4):389-92. PubMed ID: 4361835
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of subinhibitory concentrations of pefloxacin on the adherence of Staphylococcus aureus to human cells.
    Desnottes JF; Diallo N; Moret G; Santonja R
    Drugs Exp Clin Res; 1987; 13(2):69-73. PubMed ID: 3472868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of Bordetella pertussis with human respiratory mucosa in vitro.
    Soane MC; Jackson A; Maskell D; Allen A; Keig P; Dewar A; Dougan G; Wilson R
    Respir Med; 2000 Aug; 94(8):791-9. PubMed ID: 10955756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bordetella pertussis attachment to respiratory epithelial cells can be impaired by fimbriae-specific antibodies.
    Rodríguez ME; Hellwig SM; Pérez Vidakovics ML; Berbers GA; van de Winkel JG
    FEMS Immunol Med Microbiol; 2006 Feb; 46(1):39-47. PubMed ID: 16420595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pulsatile delivery of clarithromycin alone or in combination with amoxicillin against Streptococcus pneumoniae.
    Leuthner KD; Cheung CM; Rybak MJ
    Antimicrob Agents Chemother; 2006 Feb; 50(2):813-6. PubMed ID: 16436754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro activity of fosfomycin alone and in combination with amoxicillin, clarithromycin and metronidazole against Helicobacter pylori compared with combined clarithromycin and metronidazole.
    Blacky A; Makristathis A; Apfalter P; Willinger B; Rotter ML; Hirschl AM
    Eur J Clin Microbiol Infect Dis; 2005 Apr; 24(4):276-9. PubMed ID: 15902535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cholesterol-rich domains are involved in Bordetella pertussis phagocytosis and intracellular survival in neutrophils.
    Lamberti Y; Perez Vidakovics ML; van der Pol LW; Rodríguez ME
    Microb Pathog; 2008 Jun; 44(6):501-11. PubMed ID: 18276103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Favourable effects of sub-MIC rufloxacin concentrations in decreasing the pathogen-host cell adhesion.
    Braga PC; Piatti G
    Pharmacol Res; 1993; 28(1):11-9. PubMed ID: 8234142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newly secreted adenylate cyclase toxin is responsible for intoxication of target cells by Bordetella pertussis.
    Gray MC; Donato GM; Jones FR; Kim T; Hewlett EL
    Mol Microbiol; 2004 Sep; 53(6):1709-19. PubMed ID: 15341649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human salivary cystatin SA exhibits antimicrobial effect against Aggregatibacter actinomycetemcomitans.
    Ganeshnarayan K; Velliyagounder K; Furgang D; Fine DH
    J Periodontal Res; 2012 Oct; 47(5):661-73. PubMed ID: 22582873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clarithromycin inhibits rhinovirus-induced bacterial adhesions to nasal epithelial cells.
    Wang JH; Lee SH; Kwon HJ; Jang YJ
    Laryngoscope; 2010 Jan; 120(1):193-9. PubMed ID: 19877190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence of Bordetella bronchiseptica and Pasteurella multocida to swine nasal ciliated epithelial cells in vitro.
    Chung WB; Collins MT; Bäckström LR
    APMIS; 1990 May; 98(5):453-61. PubMed ID: 2357345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Epidemiological surveillance of Bordetella pertussis and parapertussis sensitivity to antibiotics].
    Janovská D; Výmola F
    Cesk Epidemiol Mikrobiol Imunol; 1971 Jul; 20(4):184-8. PubMed ID: 4328643
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.